Leaphy 1A
Leaphy, the single trusted source for information about medicines and more
€131,700
total amount raised in round
- Backed by over 70 investors
- Eligible for a tax reduction
Campaign Closed
At present, the capital of Leaphy amounts to €100,000. It is represented by 100,000 shares.
The capital increase in which Spreds Finance will participate into a broader financing of Leaphy planned to be between € 100,000 and € 900,000. This financing can be broken down as follows:
- Between € 50,000 and € 300,000 (depending on the result of the issue of the Notes) shall be contributed by Spreds Finance in a capital increase at a pre-money valuation of € 2,900,000.
- Between € 50,000 and € 850,000 shall be contributed by other investors (e.g. business angels, …) at a pre-money valuation of € 2,900,000.
Prior to the Capital Increase, Leaphy has been valued at €2,900,000. The value of Leaphy following the Capital Increase can be estimated between € 3,000,000 and €3,800,000 i.e. the pre-money valuation of Leaphy increased by an amount between € 100,000 and € 900,000 contributed in the Capital Increase.
The capital increase in which Spreds Finance will participate into a broader financing of Leaphy planned to be between € 100,000 and € 900,000. This financing can be broken down as follows:
- Between € 50,000 and € 300,000 (depending on the result of the issue of the Notes) shall be contributed by Spreds Finance in a capital increase at a pre-money valuation of € 2,900,000.
- Between € 50,000 and € 850,000 shall be contributed by other investors (e.g. business angels, …) at a pre-money valuation of € 2,900,000.
Prior to the Capital Increase, Leaphy has been valued at €2,900,000. The value of Leaphy following the Capital Increase can be estimated between € 3,000,000 and €3,800,000 i.e. the pre-money valuation of Leaphy increased by an amount between € 100,000 and € 900,000 contributed in the Capital Increase.